Myriad Genetics, Inc. (NASDAQ:MYGN) Receives $24.20 Consensus Target Price from Brokerages
Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) has been given an average recommendation of “Hold” by the five brokerages that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and two have assigned a buy recommendation to the […]